SG
Suman Gupta
About Suman Gupta
Data last updated:
Suman Gupta is a Director at Forelab Biosciences Private Limited (since 2022), Director at Kumar Pathology Private Limited (since 2021) and Director at Shraysht Solutions India Private Limited (since 2021). The companies operate in Electrnoics, Non-Profit Organizations and Business Outsourcing.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 08 Jun 2022 | 2022 | Active | ||
| Director | 05 Oct 2021 | 2021 | Active | ||
| Director | 16 Jul 2021 | 2014 | Active |
Board colleagues of Suman Gupta
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ashok Kumar Gupta | 09347905 | Forelab Biosciences Private Limited , Kumar Pathology Private Limited | Director |
| Saransh Singhal | 06947563 | Kumar Pathology Private Limited , Shraysht Solutions India Private Limited | Director |
| Parkhi Singhal | 06789565 | Shraysht Solutions India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Suman Gupta
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Suman Gupta
Suman Gupta currently holds 3 directorships: Forelab Biosciences Private Limited (Director, since 08 Jun 2022); Kumar Pathology Private Limited (Director, since 05 Oct 2021); Shraysht Solutions India Private Limited (Director, since 16 Jul 2021).
Suman Gupta was first appointed on 16 Jul 2021 as Director at Shraysht Solutions India Private Limited. The most recent appointment on record is 08 Jun 2022 at Forelab Biosciences Private Limited.
The current boards of Suman Gupta's companies include Ashok Kumar Gupta (Forelab Biosciences Private Limited), Saransh Singhal (Kumar Pathology Private Limited), Parkhi Singhal (Shraysht Solutions India Private Limited).